Acyclovir and Mitomycin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Acyclovir (acyclovir) and Mitomycin (mitomycin). Common drug interactions include skin exfoliation among females and renal failure among males.

The phase IV clinical study analyzes what interactions people have when they take Acyclovir and Mitomycin. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Acyclovir?

Acyclovir has active ingredients of acyclovir. It is often used in herpes simplex. eHealthMe is studying from 54,961 Acyclovir users. Check the latest studies of Acyclovir.

What is Mitomycin?

Mitomycin has active ingredients of mitomycin. eHealthMe is studying from 4,195 Mitomycin users. Check the latest studies of Mitomycin.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 14, 2026

19 people who take Acyclovir and Mitomycin together, and have interactions are studied.

Acyclovir and Mitomycin drug interactions.

What are the common drug interactions of Acyclovir and Mitomycin, by gender? *:

female:

  1. Skin exfoliation (removal of the oldest dead skin cells)
  2. Stridor
  3. Dyspnoea (difficult or laboured respiration)
  4. Oral candidiasis (fungal infection of mouth)
  5. Respiratory moniliasis (fungal infection of respiratory system)
  6. Cd4 lymphocytes decreased
  7. Epiglottic oedema (swelling and inflammation of the epiglottis)
  8. Lymphocyte count decreased
  9. Candidiasis (candidiasis or thrush is a fungal infection)
  10. Laryngeal inflammation (infection of larynx)

male:

  1. Renal failure (kidney dysfunction)
  2. Acute myeloid leukaemia recurrent (acute cancer in which the bone marrow makes abnormal myeloblast- recurrent)
  3. Drug ineffective
  4. Transplant rejection (a transplant material is not worked)
  5. Corneal graft rejection
  6. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  7. Anxiety
  8. Back pain
  9. Chronic kidney disease
  10. Emotional distress

What are the common drug interactions of Acyclovir and Mitomycin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Corneal graft rejection
  2. Transplant rejection (a transplant material is not worked)

30-39:

n/a

40-49:

n/a

50-59:

  1. Renal failure (kidney dysfunction)
  2. Acute myeloid leukaemia recurrent (acute cancer in which the bone marrow makes abnormal myeloblast- recurrent)
  3. Bacterial infection
  4. Blood immunoglobulin g decreased
  5. Cataract (clouding of the lens inside the eye)
  6. Chimerism (fertilization of two separate ova by two sperm)
  7. Immunosuppression
  8. Obstructive airways disorder (a progressive disease that makes it hard to breathe)
  9. Osteoporosis (bones weak and more likely to break)
  10. Respiratory syncytial virus infection (viral disease of respiratory system)

60+:

  1. Skin exfoliation (removal of the oldest dead skin cells)
  2. Stridor
  3. Laryngitis fungal (inflammation of the larynx due to fungal infection)
  4. Lymphopenia (an abnormally low level of lymphocytes in the blood)
  5. Oropharyngeal candidiasis (fungal infection of oropharynx)
  6. Transplant rejection (a transplant material is not worked)
  7. Dyspnoea (difficult or laboured respiration)
  8. Oral candidiasis (fungal infection of mouth)
  9. Respiratory moniliasis (fungal infection of respiratory system)
  10. Cd4 lymphocytes decreased

What are the existing conditions these people have? *

  1. Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 11 people, 57.89%
  2. Chronic Graft Versus Host Disease (immune cells attack the host's body cells after transplant): 11 people, 57.89%
  3. Anal Cancer: 3 people, 15.79%
  4. Oral Candidiasis (fungal infection of mouth): 1 person, 5.26%
  5. Hiv Infection: 1 person, 5.26%
  6. Anal Cancer Stage Ii: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Acyclovir and Mitomycin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Acyclovir and Mitomycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Acyclovir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Mitomycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Acyclovir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mitomycin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on acyclovir and mitomycin (the active ingredients of Acyclovir and Mitomycin, respectively), and Acyclovir and Mitomycin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: